Several genes encoding components of the PI3K–AKT–mTOR pathway have been implicated in FCD, and targeted testing of PI3K–AKT–mTOR pathway genes, using highly sensitive sequencing methods that allowed detection of low-frequency brain somatic variants, produced diagnostic yields ranging from 12% to 40%55–57. This evidence concerns the gene MTOR and fleck corneal dystrophy.